NCT06060652View on ClinicalTrials.gov

Prostate Oligometastatic Cancer Management Driven by Disease Biology et/or Immunoactivity (PROMETEO)

RecruitingOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

May 11, 2023

Primary Completion Date

May 11, 2026

Study Completion Date

May 11, 2026

Conditions
Oligometastatic Prostate Cancer
Trial Locations (2)

33081

RECRUITING

IRCCS-Centro di Riferimento Oncologico (CRO) di Aviano, Aviano

Unknown

RECRUITING

ASST Spedali Civili, Brescia

All Listed Sponsors
lead

Centro di Riferimento Oncologico - Aviano

OTHER